Zilbrysq ucb holdings?

I’m not finding a drug or term exactly spelled “Zilbrysq” in UCB’s portfolio. It could be a misspelling, a code name, or something else.

Could you clarify one of these?
- Do you mean a drug product? If so, please check the spelling or share any indication, country, or context (e.g., what it’s used for).
- Do you mean UCB Holdings (the company’s corporate structure/portfolio)? If so, I can give an overview of UCB’s business, major marketed medicines, and recent developments.
- Are you looking for regulatory status, dosing/safety, or financial/ownership information?

If you want, I can also outline UCB’s major marketed medicines (like Cimzia, Vimpat, Dayvigo, Nayzilam) and point you to where to look for the most up-to-date regulatory and corporate information.